<?xml version="1.0" encoding="UTF-8"?>
<p id="Par30">Hydroxychloroquine (an anti-malarial drug) administration has emerged as a popular and effective strategy to treat COVID-19 patients worldwide. The drug alleviates inflammation and resultant respiratory distress by neutralizing the pro-inflammatory cytokine (such as IL-6) and macrophage response (Brufsky 
 <xref ref-type="bibr" rid="CR2">2020</xref>). The drug may also act as anti-viral by inhibiting virus replication inside host cells and by decreasing ACE2 affinity for spike glycoprotein (Sinha and Balayla 
 <xref ref-type="bibr" rid="CR29">2020</xref>).
</p>
